FIELD: medicine.
SUBSTANCE: method involves removing pathological content from urogenital tract. To do it, 4-5 ml of aqueous mixture of iron nanopowder is introduced into urethra for 40-60 min. Then permanent magnetic field is endourethrally applied.
EFFECT: enhanced effectiveness of treatment.
| Title | Year | Author | Number | 
|---|---|---|---|
| AGENT FOR TREATMENT OF PATIENTS WITH CHRONIC PROSTATITIS | 1996 | 
 | RU2139726C1 | 
| METHOD FOR APPLYING COMPLEX THERAPY OF CHRONIC URETHRITIS PRODUCED BY UROGENITAL INFECTIONS | 2000 | 
 | RU2170599C1 | 
| METHOD FOR TREATMENT OF CHRONIC PROSTATIS | 1998 | 
 | RU2172189C2 | 
| METHOD FOR TREATING THE CASES OF CHRONIC PROSTATITIS | 2001 | 
 | RU2199353C2 | 
| METHOD OF CHRONIC PROSTATITIS TREATMENT | 1997 | 
 | RU2143249C1 | 
| METHOD FOR TREATING CHRONIC PROSTATITIS | 2001 | 
 | RU2203673C2 | 
| METHOD FOR TREATING THE CASES OF CHRONIC INFECTIOUS PROSTATITIS | 2000 | 
 | RU2175862C1 | 
| METHOD FOR COMPLEX TREATMENT OF CHRONIC PROSTATITIS | 2001 | 
 | RU2205622C1 | 
| METHOD FOR DETERMINING THERAPY EFFECTIVENESS IN CHRONIC URETHROGENOUS PROSTATITIS PATIENTS | 1999 | 
 | RU2145088C1 | 
| METHOD AND DEVICE FOR TREATING THE CASES OF CHRONIC PROSTATITIS | 2000 | 
 | RU2195971C2 | 
Authors
Dates
2006-04-27—Published
2004-05-11—Filed